PHOENIX BIOTECH ACQUISITION CORP. (ticker: PBAX)

PBAX

Definitive Agreement

CERo Therapeutics

PBAXU

First	2021-10-06	$10.08
Recent	2024-02-14	$10.37	3%

PHOENIX BIOTECH ACQUISITION CORP.

Sponsors: Phoenix Biotech Sponsor

Underwriter: Cantor Fitzgerald

Leadership: Chris Ehrlich, Daniel Geffken, Douglas Fisher, Brian G. Atwood, Kathleen LaPorte, Barbara Kosacz, Caroline Loewy

Raised: $155M
CIK: 1870404
SPAC Ticker: PBAXU
Merger: CERo Therapeutics
Focus: Healthcare, Life Sciences

Sign in for detailed analysis →

External link: SEC Filings